SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is facing significant volatility as investors weigh strong quarterly growth and major contract wins against mounting concerns regarding AI-driven disruption to the broader software sector. While the community remains deeply divided between those viewing the pullback as a structural repricing and those treating the current price as a long-term entry point, the stock is struggling to maintain support amidst intense selling pressure and a sector-wide rotation away from high-multiple SaaS names.

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals is experiencing significant volatility and trading interest as investors weigh the company's substantial cash position against a pivotal upcoming clinical data readout. Community sentiment is deeply divided, with some traders optimistic about potential institutional accumulation and buyout speculation, while others express concerns over the stock's recent price decline and the long timeline to future trial milestones.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing high volatility as the stock reacts to an expanded multi-year compute deal with Meta and a new partnership with Anthropic. While the community is actively debating the stock's long-term potential in AI infrastructure, enthusiasm is tempered by concerns over the concurrent announcement of a $3.5 billion convertible note offering and its potential for shareholder dilution.

One & One Green Technologies, Inc. engages in the recycling, production, and trading of recycled scrap metals. Its products include copper alloy ingot, recycled aluminum, recycled tin, recycled zinc, recycled iron, and plastic beads. The company was founded on April 17, 2024 and is headquartered in Bulacan, Philippines.

One and one Green Technologies. Inc - Ordinary Shares - Class A

One and One Green Technologies Inc

One and One Green Technologies (YDDL) is seeing extreme volatility following its recent NASDAQ debut, with investors closely watching its low-float status and aggressive intraday price swings. Community discourse is sharply divided between those betting on a potential short squeeze due to insider ownership and those skeptical of the company's fundamentals as a Philippines-based recycler.

Renaissance Capital Greenwich Funds - Renaissance IPO ETF

The IPO market is currently experiencing a significant surge in activity, driven by a wave of high-profile filings from major technology and financial services companies. Market participants are actively debating the sustainability of this momentum, weighing strong investor interest in emerging AI and crypto sectors against concerns regarding valuation premiums and liquidity conditions.

GraniteShares ETF Trust - GraniteShares 2x Long NBIS Daily ETF

GraniteShares 2x Long NBIS Daily ETF

The GraniteShares 2x Long NBIS Daily ETF (NBIL) is trending as traders utilize the vehicle to capture leveraged exposure to the price movements of Nebius Group (NBIS). Community members are actively sharing their swing-trading strategies and entry points, driven by both technical setups and high expectations for potential growth in the underlying stock.

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is attracting significant community attention due to its focus on enterprise-grade data validation and its existing contracts with U.S. defense agencies. Investors are highlighting its unique DAG-based architecture as a scalable alternative to traditional blockchains, positioning it as a key infrastructure play for the growing AI and secure data integrity sectors.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing significant upward momentum driven by a $2 billion strategic investment from Nvidia aimed at bolstering AI infrastructure and cloud connectivity. The community is actively discussing the stock's transition from a standard semiconductor play to a critical AI infrastructure bet, with many investors anticipating further price appreciation as optics and custom AI chips become essential components for hyperscalers.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is facing heavy selling pressure amid a broader market rotation out of high-multiple software stocks, with investors weighing concerns over long-term AI disruption against its strong product retention. While many traders see the current weakness as an overreaction and a potential accumulation opportunity, sentiment remains divided as the community debates whether the stock is finding a bottom or heading toward lower valuations.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. It offers various products for performance and reliability, video streaming and delivery, advanced security, insights, Cloudflare for developers, domain registration, and Cloudflare marketplace. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflare is trending following a strong quarterly earnings report that beat revenue and earnings expectations, with leadership framing the company as essential infrastructure for the growing agentic AI ecosystem. Investors are currently weighing this robust operational performance against broader volatility in the software and cybersecurity sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Design Therapeutics, Inc. (NASDAQ:DSGN) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six analysts that are currently covering the stock, Marketbeat.com...

Design Therapeutics (NASDAQ:DSGN) Hits New 1-Year High - What's Next?

Design Therapeutics (NASDAQ:DSGN) Hits New 12-Month High - Here's What Happened...

Design Therapeutics (NASDAQ:DSGN) Trading Up 6.8%  - Still a Buy?

Design Therapeutics (NASDAQ:DSGN) Stock Price Up 6.8% - Should You Buy...

Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - Here's What Happened

Design Therapeutics (NASDAQ:DSGN) Reaches New 12-Month High - What's Next...

Design Therapeutics (NASDAQ:DSGN) Sets New 1-Year High - Here's Why

Design Therapeutics (NASDAQ:DSGN) Hits New 52-Week High - What's Next...

Design Therapeutics (NASDAQ:DSGN) Sees Unusually-High Trading Volume - Time to Buy?

Design Therapeutics (NASDAQ:DSGN) Sees Large Volume Increase - Should You Buy...

Design Therapeutics (NASDAQ:DSGN) Now Covered by Jefferies Financial Group

Jefferies Financial Group started coverage on Design Therapeutics in a research note on Monday. They set a "buy" rating and a $15.00 price target on the stock...

Design Therapeutics Maps H2 Data Readouts for RESTORE-FA, FECD Biomarker Study and DM1 Program

Design Therapeutics (NASDAQ:DSGN) outlined its near-term clinical priorities and key upcoming data readouts during a conference discussion with Leerink Partners' Joe Schwartz, featuring comments from...

Design Therapeutics, Inc. (NASDAQ:DSGN) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Design Therapeutics, Inc. (NASDAQ:DSGN - Get Free Report) have earned a consensus rating of "Moderate Buy" from the five brokerages that are presently covering the company, MarketBeat.com...

Design Therapeutics (NASDAQ:DSGN) Stock Price Up 6.7% After Analyst Upgrade

Design Therapeutics (NASDAQ:DSGN) Shares Up 6.7% on Analyst Upgrade...

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Current Price	$12.16
Prev Close	$12.49
Open	$12.50
Dividend Yield	0.00%
50-Day Moving Average	$10.57
Beta	1.62
Avg. Volume	282,414.55
PE Ratio	-9.98

52-Week High	$12.84
52-Week Low	$2.88
Market Capitalization	$770.29M
EPS (Annual)	-$1.22
Price to Book	3.46
Revenue Per Employee	$0.00

DSGN
Design Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DSGN News

DSGNDesign Therapeutics Inc